Log In
Print this Print this

Tirosint, levothyroxine

  Manage Alerts
Collapse Summary General Information
Company Institut Biochimique S.A.
DescriptionOral levothyroxine sodium capsules
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationThyroid disease
Indication DetailsReplacement or supplemental therapy in congenital or acquired hypothyroidism, to treat or prevent euthyroid goiters and as adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well differentiated thyroid cancer; Treat hypothyroidism
Regulatory Designation
PartnerAkrimax Pharmaceuticals LLC

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today